Adrienne Feasel, MD
Basic profileThe University of Texas MD Anderson Cancer Center
Adrienne Feasel is a Dermatology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 8 publications with 315 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11671 Jollyville Rd
#104
Austin, TX 787593933
Telephone
512-345-3599Registry record last updated 8 Jul 2007.
Industry payments
31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202520 payments
- Janssen Biotech, Inc.Program year202522 payments
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
81.9%Porphyrin Precursor79.2%Aminolevulinic acid hcl100%Part B, office-administered≥13 patientsInterleukin-17A Antagonist0.9%Taltz Autoinjector57%Cosentyx Sensoready (2 Pens)43%Part D<11 patients+ 3 more classes in this area
Anti-infectives
6.8%Tetracycline-class Drug2.8%Doxycycline Hyclate54%Doxycycline Monohydrate25%Minocycline Hcl21%Part D<11 patientsAzole Antifungal1.3%Ketoconazole100%Part D≥28 patients+ 3 more classes in this area
Dermatology
3.4%Corticosteroid2.9%Triamcinolone Acetonide65%Triamcinolone acetonide35%Part D + Part B≥45 patientsPediculicide0.5%Ivermectin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Photo quiz. Koebner streak.
PubMed
2002
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”